The progress of study on hyperuricemia

Chinese Pharmacological Bulletin

Volumn 19, Issue 10, 2003, Pages 1088-1092

  Chen, Guang Liang ^a   Xu, Shu Yun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Gout; Hyperuricemia; Purine; Uric acid

Indexed keywords

HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; RIBOSEPHOSPHATE PYROPHOSPHOKINASE; URIC ACID;

DISEASE ASSOCIATION; GOUT; HUMAN; HYPERURICEMIA; INSULIN RESISTANCE; KIDNEY DISEASE; NEPHROLITHIASIS; PREVALENCE; PURINE METABOLISM; REVIEW; URINARY EXCRETION;

EID: 0242323533     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Arromdee E, Michet CJ, Crowson CS et al. Epidemiology of gout is the incidence rising? J Rheumatol, 2002;29(11):2403-6
2. Yu KH, Luo SF. Younger age of onset of gout in Taiwan. Rheumatology (Oxford), 2003;42(1):166-70
3. Chang HY, Pan WH, Yeh WT, Tsai KS. Hyperuricemia and gout in Taiwan: Results from the nutritional and health survey in Taiwan (1993-96). J Rheumatol, 2001;28(7):1640-6
4. Tomita M, Mizuno S, Yamanaka H, Hosoda Y. Does hyperuricemia affect mortality? A prospective cohort study of Japanese male workers. J Epidemiol, 2000;10(6):403-9
5. Mazzali M, Hughes J, Kim YG et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension, 2001;38(5):1101-6
6. Lipkowitz MS, Leal-Pinto E, Rappoport JZ et al. Functional reconstitution, membrane targeting, genomic structure, and chromosomal localization of a human urate transporter. J Clin Invest, 2001;107(9):1103-5
7. Reed DR, Price RA. X-linkage does not account for the absence of father-son similarity in plasma uric acid concentration. Am J Med Genet, 2000;92(2):142-6
8. Chen SY, Chen CL, Shen ML, Kamatani N. Clinical features of familial gout and effects of probable genetic association between gout and its related disorders. Metabolism, 2001;50 (10):1203-7
9. Zuo M, Nishio H, Lee MJ et al. The C677T mutation in the methylene tetrahydrofolate reductase gene increases serum uric acid in elderly men. J Hum Genet, 2000;45(4):257-62
10. Hayashi H, Nagasaka S, Ishikawa S et al. Contribution of a missence mutation (Trp64Arg) in beta3-adrenergic receptor gene to multiple risk factors in Japanese men with hyperuricemia. Endocr J, 1998;45(6):779-84
11. Fruehwald-Schultes B, Peters A, Kern W et al. Serum leptin is associated with serum uric acid concentrations in humans. Metabolism, 1999;48(6):677-80
12. 2 in patients with gout is associated with reduced renal excretion of urates. Rheumatology (Oxford), 2003;42(3):468-72
13. Ghei M, Mihailescu M, Levinson D. Pathogenesis of hyperuricemia: Recent advances. Curr Rheumatol Rep, 2002;4(3):270-4
14. Stiburkova B, Majewski J, Sebesta I et al. Familial juvenile hyperuricemic nephropathy: Localization of the gene on chromosome 16p1. 2-and evidence for genetic heterogeneity. Am J Hum Genet, 2000;66(6):1989-94
15. Kamatani N, Moritani M, Yamanaka H et al. Localization of a gene for familial juvenile hyperuricemic nephropathy causing underexcretion-type gout to 16p2 by genome-wide linkage analysis of a large family. Arthritis Rheum, 2000;43(4):925-9
16. Turner JJ, Stacey JM, Harding B et al. Uromodulin mutations cause familial juvenile hyperuricemic nephropathy. J Clin Endocrinol Metab, 2003;88(3):1398-401
17. Ahmed M, Taylor W, Smith PR, Becker MA. Accelerated transcription of PRPS1 in X-linked overactivity of normal human phosphoribosylpyrophosphate synthetase. J Biol Chem, 1999;274(11):7482-8
18. Mak BS, Chi CS, Tsai CR et al. New mutations of the HPRT gene in Lesch-Nyhan syndrome. Pediatr Neurol, 2000;23(4): 332-5
19. Jinnah HA, De-Gregorio L, Harris JC et al. The spectrum of inherited mutations causing HPRT deficiency: 75 new cases and a review of 196 previously reported cases. Mutat Res, 2000;463 (3):309-26
20. Chang SJ, Chang JG, Chen CJ et al. Identification of a new single nucleotide substitution on the hypoxanthine-guanine phosphoribosyltransferase gene (HPRT(Tsou)) from a Taiwanese aboriginal family with severe gout. J Rheumatol, 1999;26(8): 1802-7
21. Nyhan WL. Dopamine function in Lesch-Nyhan disease. Environ Health Perspect, 2000;108(Suppl 3):409-11
22. Chou JY, Matern D, Mansfield BC, Chen YT. Type I glycogen storage diseases: Disorders of the glucose-6-phosphatase complex. Curr Mol Med, 2002;2(2):121-43
23. Matern D, Seydewitz HH, Bali D et al. Glycogen storage disease type I: Diagnosis and phenotype/genotype correlation. Eur J Pediatr, 2002;161(Suppl 1):10-9